Government Backs New AI Healthcare Regulations to Accelerate Safe NHS Innovation
The UK Government has accepted all 44 recommendations from the National Commission into the Regulation of AI in Healthcare, paving the way for a new approach to safely introducing artificial intelligence across the NHS.
Published in response to the NHS doctors-led Commission, the reforms aim to accelerate access to innovative AI healthcare technologies while strengthening patient safety, transparency and public trust.
Central to the plans is a move towards lifecycle-based regulation of AI-enabled medical devices. Rather than relying heavily on a one-off assessment, AI technologies could be continuously monitored throughout their use to understand how they perform in real-world healthcare settings.
The Medicines and Healthcare products Regulatory Agency (MHRA) has also opened applications for Phase 3 of its AI Airlock regulatory sandbox, which allows developers, regulators and healthcare organisations to test approaches to AI medical device regulation.
Bringing AI innovation safely into the NHS
AI Airlock Phase 3 will focus on post-market surveillance, exploring how artificial intelligence technologies can be monitored after deployment and providing evidence to shape future MHRA guidance.
Further reforms include exploring staged authorisation pathways, potentially allowing promising AI healthcare tools to enter NHS settings earlier under close supervision while additional real-world evidence is collected.
The MHRA is expected to issue draft guidance by December 2026 covering how AI-enabled medical devices should be managed as they adapt and improve over time.
Health Innovation Minister James Frith said the government wants patients to benefit from the “life-saving potential of AI”, while ensuring new technologies remain safe, effective and properly regulated.
Patient involvement will also form a key part of the new approach, with commitments to improve transparency around when AI is being used in healthcare, strengthen access to redress and ensure new technologies benefit communities fairly.
The reforms could have significant implications for the UK’s growing health technology and life sciences sectors, providing developers with greater clarity while supporting the adoption of AI across the NHS.
A full implementation roadmap covering all 44 recommendations is expected by spring 2027, setting out how the UK intends to establish a safer, faster and more agile regulatory framework for AI in healthcare.
